Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Geophys Res Lett ; 48(12): e2020GL091709, 2021 Jun 28.
Artigo em Inglês | MEDLINE | ID: mdl-34219834

RESUMO

We present a new solar irradiance reference spectrum representative of solar minimum conditions between solar cycles 24 and 25. The Total and Spectral Solar Irradiance Sensor-1 (TSIS-1) Hybrid Solar Reference Spectrum (HSRS) is developed by applying a modified spectral ratio method to normalize very high spectral resolution solar line data to the absolute irradiance scale of the TSIS-1 Spectral Irradiance Monitor (SIM) and the CubeSat Compact SIM (CSIM). The high spectral resolution solar line data are the Air Force Geophysical Laboratory ultraviolet solar irradiance balloon observations, the ground-based Quality Assurance of Spectral Ultraviolet Measurements In Europe Fourier transform spectrometer solar irradiance observations, the Kitt Peak National Observatory solar transmittance atlas, and the semi-empirical Solar Pseudo-Transmittance Spectrum atlas. The TSIS-1 HSRS spans 202-2730 nm at 0.01 to ∼0.001 nm spectral resolution with uncertainties of 0.3% between 460 and 2365 nm and 1.3% at wavelengths outside that range.

2.
Circulation ; 104(11): 1292-8, 2001 Sep 11.
Artigo em Inglês | MEDLINE | ID: mdl-11551882

RESUMO

BACKGROUND: Numerous pathological mediators of cardiac hypertrophy (eg, neurohormones, cytokines, and stretch) have been shown to activate p38 MAPK. The purpose of the present study was to examine p38 MAPK activation and the effects of its long-term inhibition in a model of hypertensive cardiac hypertrophy/dysfunction and end-organ damage. METHODS AND RESULTS: In spontaneously hypertensive stroke-prone (SP) rats receiving a high-salt/high-fat diet (SFD), myocardial p38 MAPK was activated persistently during the development of cardiac hypertrophy and inactivated during decompensation. Long-term oral treatment of SFD-SP rats with a selective p38 MAPK inhibitor (SB239063) significantly enhanced survival over an 18-week period compared with the untreated group (100% versus 50%). Periodic echocardiographic analysis revealed a significant reduction in LV hypertrophy and dysfunction in the SB239063-treatment groups. Little or no difference in blood pressure was noted in the treatment or vehicle groups. Basal and stimulated (lipopolysaccharide) plasma tumor necrosis factor-alpha concentrations were reduced in the SB239063-treatment groups. In vitro vasoreactivity studies demonstrated a significant preservation of endothelium-dependent relaxation in animals treated with the p38 MAPK inhibitor without effects on contraction or NO-mediated vasorelaxation. Proteinuria and the incidence of stroke (53% versus 7%) were also reduced significantly in the SB239063-treated groups. CONCLUSIONS: These results demonstrate a crucial role for p38 MAPK in hypertensive cardiac hypertrophy and end-organ damage. Interrupting its function with a specific p38 MAPK inhibitor halts clinical deterioration.


Assuntos
Cardiomegalia/fisiopatologia , Hipertensão/fisiopatologia , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Animais , Cardiomegalia/enzimologia , Cardiomegalia/mortalidade , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Ecocardiografia , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/fisiopatologia , Ativação Enzimática , Coração/efeitos dos fármacos , Coração/fisiopatologia , Hemodinâmica/efeitos dos fármacos , Imidazóis/farmacologia , Rim/efeitos dos fármacos , Rim/fisiopatologia , Lipopolissacarídeos/farmacologia , Masculino , Proteínas Quinases Ativadas por Mitógeno/antagonistas & inibidores , Miocárdio/metabolismo , Miocárdio/patologia , Fosforilação , Proteinúria/prevenção & controle , Proteinúria/urina , Pirimidinas/farmacologia , Ratos , Ratos Endogâmicos SHR , Ratos Endogâmicos WKY , Acidente Vascular Cerebral/patologia , Acidente Vascular Cerebral/prevenção & controle , Taxa de Sobrevida , Fatores de Tempo , Fator de Necrose Tumoral alfa/efeitos dos fármacos , Fator de Necrose Tumoral alfa/metabolismo , Vasodilatação/efeitos dos fármacos , Proteínas Quinases p38 Ativadas por Mitógeno
3.
Appl Opt ; 33(19): 4273-85, 1994 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-20935784

RESUMO

One of the many calibrations performed for a scientific-quality spectrometer is the characterization of its scattered-light properties. The scattered light can arise from any optical surface, and light leaks or scattering from baffles can also contribute to the instrumental stray-light level. For a diffraction-grating spectrometer the primary contribution to instrumental scattered light has been found to be the scattered light from the grating. The results from measuring the scattered-light properties of 10 diffraction gratings are discussed along with the application of these results in analyzing the total scattered light measured for three spectrometers. It has been found from these measurements that there are two components of the grating scattered light: a Lorentzian-type component and a constant background component. The Lorentzian component is predicted from the diffraction theory for a grating, and the constant background component is consistent with Rayleigh scattering from the microscopic surface im erfections. It was also discovered that multiple replicas of gratings from the same master grating exhibit significantly more scattered light than the preceding replica by factors of 1.1-2.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA